Integer ITGR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Integer (ITGR) Business Model and Operations Summary
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
Key Insights
Integer (ITGR) Core Market Data and Business Metrics
Latest Closing Price
$118.56Market Cap
$4.16 BillionPrice-Earnings Ratio
35.29Total Outstanding Shares
33.62 Million SharesTotal Employees
11,000Dividend
No dividendIPO Date
September 28, 2000SIC Description
Electromedical & Electrotherapeutic ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
5830 Granite Parkway., Suite 1150, Plano, TX, 75024
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $205.21 Million |
| Net Cash Flow, Continuing | $23.11 Million |
| Net Cash Flow From Financing Activities, Continuing | $13.32 Million |
| Net Cash Flow From Investing Activities, Continuing | $-195.41 Million |
| Net Cash Flow From Financing Activities | $13.32 Million |
| Exchange Gains/Losses | $-243,000 |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Income Tax Expense/Benefit, Deferred | $-14.11 Million |
| Operating Expenses | $250.78 Million |
| Diluted Average Shares | $35.65 Million |
| Income/Loss From Equity Method Investments | $-533,000 |
| Income/Loss From Continuing Operations Before Tax | $147.56 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $85.63 Million |
| Comprehensive Income/Loss Attributable To Parent | $85.63 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-34.27 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Current Liabilities | $227.17 Million |
| Equity | $1.62 Billion |
| Equity Attributable To Noncontrolling Interest | $0 |
| Liabilities And Equity | $3.08 Billion |
| Other Non-current Liabilities | $241.43 Million |
| Intangible Assets | $778.29 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||